↓ Skip to main content

Cochrane Database of Systematic Reviews

Azapirones versus placebo for panic disorder in adults

Overview of attention for article published in Cochrane database of systematic reviews, September 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

twitter
3 tweeters
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
180 Mendeley
Title
Azapirones versus placebo for panic disorder in adults
Published in
Cochrane database of systematic reviews, September 2014
DOI 10.1002/14651858.cd010828.pub2
Pubmed ID
Authors

Hissei Imai, Aran Tajika, Peiyao Chen, Alessandro Pompoli, Giuseppe Guaiana, Mariasole Castellazzi, Irene Bighelli, Francesca Girlanda, Corrado Barbui, Markus Koesters, Andrea Cipriani, Toshi A Furukawa

Abstract

Panic disorder is common in the general population. It is often associated with other psychiatric disorders, such as drug dependence, major depression, bipolar disorder, social phobia, specific phobia and generalised anxiety disorder. Azapirones are a class of drugs used as anxiolytics. They are associated with less drowsiness, psychomotor impairment, alcohol potentiation and potential for addiction or abuse than benzodiazepines. However, azapirones are not widely used in the treatment of panic disorder and evidence for their efficacy is unclear. It is important to find out if azapirones are effective and acceptable in the treatment of panic disorder.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 180 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 179 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 39 22%
Student > Bachelor 25 14%
Student > Ph. D. Student 15 8%
Researcher 14 8%
Student > Doctoral Student 13 7%
Other 27 15%
Unknown 47 26%
Readers by discipline Count As %
Medicine and Dentistry 47 26%
Psychology 31 17%
Nursing and Health Professions 12 7%
Social Sciences 9 5%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Other 17 9%
Unknown 55 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2022.
All research outputs
#5,977,649
of 23,106,934 outputs
Outputs from Cochrane database of systematic reviews
#7,760
of 12,367 outputs
Outputs of similar age
#61,936
of 253,560 outputs
Outputs of similar age from Cochrane database of systematic reviews
#156
of 225 outputs
Altmetric has tracked 23,106,934 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 12,367 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.3. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,560 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 225 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.